BASG and companies

News

News

Current issue of “RMS NEWS”

messages in brief | 30/06/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

Current issue of “RMS NEWS”

messages in brief | 30/04/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

Current issue of “RMS NEWS”

messages in brief | 29/01/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

BREXIT – End of transition period

messages in brief | 22/01/2021
The United Kingdom has left the European Union and the transition period ended on 31 December 2020. This article gives a short overview about the current applicable rules.
BREXIT – End of transition period Read more
News

Accessible Patient Information leaflet

messages in brief | 17/12/2020
Due to current events, FAQ No. 2 on accessible information for use has been revised, to better reflect the current approach.
Accessible Patient Information leaflet Read more

Information

Reporting to BASG

Reporting to BASG

The Federal Office relies on reports from consumers, health care professionals and companies for the continuous re-evaluation of the safety profile of medicinal products and medical devices.

Reporting to BASG read more
BREXIT

BREXIT

The transition period ended on 31.12.2020. Marketing authorisation holders are reminded to submit any outstanding amendments without delay.

BREXIT read more
Clinical Trials

Clinical Trials

The BASG authorises and monitors the conduct of clinical trials with medicinal products and medical devices.

Clinical Trials read more
Austrian Pharmacopoeia

Austrian Pharmacopoeia

The Austrian Pharmacopoeia (ÖAB) is a national addendum to the European Pharmacopoeia and is currently being revised by the ÖAB Commission.

Austrian Pharmacopoeia read more